Federal Rule on Youth Gender-Affirming Care Sparks Wave of Lawsuits

A coalition of 19 states is suing the federal government to stop a new rule that would restrict gender-affirming medical care for minors. The rule, proposed by the Trump administration, would cut federal funding to hospitals and clinics that provide treatments like puberty blockers and hormone therapy to transgender adolescents [33670][29682][29896].

The lawsuits argue the policy is an illegal overreach that contradicts established medical science and harms vulnerable youth. The rule seeks to reinterpret Section 1557 of the Affordable Care Act, which bans discrimination in healthcare. Under the new interpretation, providing gender-affirming care to minors would be considered discriminatory, allowing the government to withhold critical funds, including Medicaid and Medicare payments, from facilities that offer such treatments [33670][29682].

"This rule is harmful, unlawful, and would deny essential, life-saving medical care to young people," said New York Attorney General Letitia James, who is leading one of the legal challenges. The coalition contends the rule forces states into an impossible choice: either forfeit federal health funding or deny patients care that is supported by every major U.S. medical association, including the American Academy of Pediatrics [30656][33670].

Medical groups have universally condemned the push to ban this care, stating it is safe, effective, and vital for the well-being of transgender youth with gender dysphoria [30656]. Opponents of the rule, including advocacy groups, have vowed immediate legal action, setting the stage for a protracted court battle over medical autonomy and federal authority [29682].

The Department of Health and Human Services (HHS), which is named in the suits, has not publicly commented on the litigation. The rule is currently set to take effect in mid-August, but the flurry of lawsuits aims to secure a court order blocking its enforcement before that date [33670][33666].